Search clinical trials for: TAK-020 CCT

Total 11357 results

Millennium Pharmaceuticals, Inc.

Completed

A Study to Evaluate Pharmacokinetics (PK) and Safety of Oral Mobocertinib in Participants With Moderate or Severe Hepatic Impairment (HI) and Normal Hepatic Function

Healthy Volunteers | Hepatic Impairment

United States
Takeda

Completed

A Study of Danavorexton (TAK-925) in Adults With Obstructive Sleep Apnea

Sleep Apnea

Australia
Millennium Pharmaceuticals, Inc.

Completed

Dose Escalation Study of MLN0128 in Participants With Advanced Malignancies

Advanced Solid Malignancies

United States, Spain
Millennium Pharmaceuticals, Inc.

Completed

A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-788 Followed by Evaluation of the Effects of a Low-Fat Meal on TAK-788 PK and Evaluation of Relative Bioavailability of TAK-788 Capsules in Healthy Participants

Healthy Volunteers

United States
Takeda

Terminated

Efficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory Failure

Sepsis

Japan
Takeda

Completed

Efficacy of Ramelteon in Subjects With Chronic Insomnia

Sleep Initiation and Maintenance Disorders

United States
Millennium Pharmaceuticals, Inc.

Completed

A Study of Mobocertinib Capsules in People With Severe Kidney Problems and People With Healthy Kidneys

Renal Impairment | Healthy Volunteers

United States
Karen D. Wright, MD
National Cancer Institute (NCI); Pacific Pediatric Neuro-Oncology Consortium; Day One Biopharmaceuticals, Inc... and other collaborators

Active, not recruiting

DAY101 In Gliomas and Other Tumors

Low-grade Glioma

United States
AstraZeneca
Takeda; Covance; Catalent; MMS Holdings, Inc

Completed

Single Ascending Dose Study of MEDI1341 in Healthy Volunteers

Parkinson's Disease

United States
AstraZeneca
Takeda

Completed

Multiple Ascending Dose Study of MEDI1341 in Patients With Parkinson's Disease

Parkinson's Disease

United States
Neurocrine Biosciences
Takeda

Completed

Study to Determine D-amino Acid Oxidase Brain Enzyme Occupancy of TAK-831 After Single-dose Oral Administration

Healthy

United Kingdom
Takeda
COUR Pharmaceutical Development Company, Inc.

Completed

Study of the Safety, Tolerability and Pharmacokinetics of TIMP-GLIA in Subjects With Celiac Disease

Celiac Disease

United States
Takeda

Completed

The Exploratory Study to Investigate the Effect of Ramelteon for Insomnia Patients With Major Depressive Disorder by Using Actigraphy

Insomnia | Major Depressive Disorder

Japan
Takeda

Completed

Pharmacokinetic and Safety of Ramelteon Between Adolescents With Insomnia and Healthy Adults

Insomnia

United States
Takeda

Completed

Efficacy & Safety of Resatorvid in Adults With Severe Sepsis

Sepsis

United States, United Kingdom, Belgium, Germany, Spain, Israel, Japan, Australia, Canada, Finland, Netherlands, New Zealand, Czech Republic, Puerto Rico, Austria, Sweden, Italy
Universidad Antonio de Nebrija

Not yet recruiting

Safety and Dosage of a Computerized Cognitive Training Program for Cognitive Dysfunction After COVID-19 (CCTLongCOVID)

Cognitive Impairment | Cognitive Dysfunction | Post Acute COVID-19 Syndrome | Post-Acute COVID-19

Spain
Parc de Salut Mar

Recruiting

Efficacy of ACT in Patients Scheduled for Lumbar Spine Surgery (SPINE-ACT)

Randomized Controlled Trial

Spain
Hospital Universitari Vall d'Hebron Research Institute

Completed

Chronic Low Back Pain: A Multidisciplinary Approach (CLBP-HUVH)

Chronic Pain

Spain
New York State Psychiatric Institute
National Institute of Mental Health (NIMH)

Completed

Recovery From Psychosis in Schizophrenia - The Impact of Cognitive-Behavioral Therapy

Schizophrenia | Schizoaffective Disorder | Schizophreniform Disorder

United States
Linnaeus University
Kronoberg County Council; Capio Group

Completed

PCBH With the Addition of Self-help CBT

Quality of Life | Stress | Insomnia | Psychological Distress | Depression, Anxiety | Activities, Daily Living

Sweden
Chengdu University of Traditional Chinese Medicine
University of Electronic Science and Technology of China

Unknown

Tai Chi for Comorbid Depression in T2DM Patients

Depression | T2DM

China
Unity Health Toronto

Recruiting

Endophthalmitis Post Intravitreal Injections (EPIIC)

Endophthalmitis

Canada
Pieris Pharmaceuticals GmbH
FGK Clinical Research GmbH

Unknown

Phase Ib Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients

Anemia of Chronic Kidney Disease

Germany
Pieris Pharmaceuticals GmbH
FGK Clinical Research GmbH

Completed

Phase 2a Study to Evaluate PRS-080 in Anemic Chronic Kidney Disease Patients

Anemia of Chronic Kidney Disease

Czechia, Germany
VA Office of Research and Development

Completed

ASPIRE Cognitive Enhancement Study (ACES)

Homelessness | Mental Health Conditions

United States
University of Aarhus

Completed

Compassion Cultivation Training (CCT): An Intervention for Caregivers

Psychological Distress

Denmark
Takeda

Recruiting

A Survey of Lanadelumab in Participants With Hereditary Angioedema

Hereditary Angioedema (HAE)

Japan
Neurocrine Biosciences

Completed

Study to Assess the Efficacy and Safety of NBI-1065845 in Adults With Major Depressive Disorder (MDD) (SAVITRI)

Major Depressive Disorder

United States, Czechia, Bulgaria, Poland, Slovakia, Sweden
Takeda

Available

Expanded Access Program of TAK-755 for Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Thrombotic Thrombocytopenic Purpura (TTP)
Takeda

Completed

Drug Use Surveillance of Vonoprazan for "Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis"

Gastric Ulcer, Duodenal Ulcer, and Reflux Esophagitis

Japan
Takeda

Completed

Efficacy and Safety of Ramelteon in Subjects With Mild to Moderate Alzheimer's Disease

Chronic Insomnia

United States
Takeda

Terminated

Efficacy of Lapaquistat Acetate on Blood Cholesterol Levels in Treating Subjects With Hypercholesterolemia

Hypercholesterolemia

Ukraine, Spain, Israel, Netherlands, Estonia, Russian Federation, Hungary, Norway, United Kingdom, Slovakia, Latvia
Technische Universität Dresden
Charite University, Berlin, Germany; University Hospital Carl Gustav Carus

Completed

Learning and Relapse Risk in Alcohol Dependence (FP2) (LeAD_FP2)

Alcohol Use Disorder

Germany
Takeda

Recruiting

An Absorption, Distribution, Metabolism, Excretion (ADME) Study of [14C]Subasumstat in Adults With Advanced or Metastatic Solid Tumors

Solid Tumors

Hungary
Takeda
Nimbus Lakshmi, Inc.

Completed

A Study to Evaluate the Efficacy, Safety, and Tolerability of NDI-034858 in Participants With Active Psoriatic Arthritis

Psoriatic Arthritis

United States, Czechia, Germany, Poland
Takeda

Completed

A Study of REPLAGAL® in Treatment-naive Chinese Participants With Fabry Disease

Fabry Disease

China
Takeda

Completed

Expanded Access Program With Lanadelumab for Japanese People With Hereditary Angioedema

Hereditary Angioedema

Japan
Takeda

Completed

Special Drug Use Surveillance of Vonoprazan for "Maintenance Therapy of Reflux Esophagitis: Long-term Use"

Reflux Esophagitis

Japan
Takeda

Completed

A Phase 2 Efficacy and Safety Study of TAK-063 in Participants With an Acute Exacerbation of Schizophrenia

Schizophrenia

United States
Takeda

Terminated

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder

Bipolar Disorder

United States, Argentina, Chile, Colombia, Mexico
Takeda

Terminated

Safety and Efficacy Study of Ramelteon (TAK-375) Tablets for Sublingual Administration (SL) in Adults With Bipolar 1 Disorder

Bipolar Disorder

United States, Ukraine, United Kingdom, Germany, Bulgaria, Romania, Serbia, Russian Federation, Czech Republic, Poland
Takeda

Terminated

Efficacy of Lapaquistat Acetate in Subjects With Hypercholesterolemia

Hypercholesterolemia

United States
Syracuse VA Medical Center
VA Office of Research and Development; Michael E. DeBakey VA Medical Center

Completed

ACT Workshops: A Novel Delivery Modality to Increase Access to Care for Rural Veterans

Psychological Distress | Access to Care

United States
Yale University
National Institute on Drug Abuse (NIDA)

Completed

Computer Based Training in Cognitive Behavioral Therapy Web-based (Man VS Machine)

Substance Abuse

United States
Massachusetts General Hospital
National Institute of Mental Health (NIMH); The Fenway Institute

Unknown

Body Image and Self-Care in HIV-Infected MSM (BUILD)

Medication Adherence | Body Image Disturbance

United States
NYU Langone Health
National Institute of Mental Health (NIMH)

Recruiting

Stress & Self-Control Costs

Self-Control

United States
Takeda

Available

Expanded Access to TAK-113 for Adults With Metastatic Colorectal Cancer (mCRC)

Colorectal Cancer
Northwestern University
Takeda

Terminated

Efficacy and Tolerability of Ramelteon in Patients With Rapid Eye Movement (REM) Behavior Disorder and Parkinsonism

Parkinsonism | REM Behavior Disorder

United States
Calithera Biosciences, Inc

Completed

Effect of Sapanisertib (MLN0128) on the QTc Interval in Participants With Advanced Solid Tumors

Advanced Solid Tumors

United States
Takeda

Completed

Phase 3 Study of TAK-438 10 mg in the Treatment of Non-Erosive Gastroesophageal Reflux Disease (NERD)

Non-erosive Gastroesophageal Reflux Disease

Japan

Search clinical trials for: TAK-020 CCT

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Moldova

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations